1. Treating infections caused by carbapenemase-producing Enterobacteriaceae 
L.S. Tzouvelekis, A. Markogiannakis, E. Piperaki, M. Souli, G.L. Daikos 
Clinical Microbiology and Infection 
Volume 20, Issue 9, Pages (September 2014)
DOI: /
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Outcomes of patients infected with carbapenemase-producing Klebsiella pneumoniae, according to treatment regimen. Regimen A: inappropriate therapy (no drug was active in vitro). Regimen B: monotherapy (one drug was active in vitro). Regimen C: combination therapy (two or more drugs were active in vitro). Regimen C1: combination therapy with two or more in vitro-active drugs not including a carbapenem. Regimen C2: combination therapy with two or more in vitro-active drugs, one of which was a carbapenem. Regimen B vs. regimen A: p, not significant. Regimens C, C1 and C2 vs. regimen B: p 0.001, p 0.034, and p <0.0001, respectively. Numbers above columns indicate the number of patients.
Clinical Microbiology and Infection  , DOI: ( / )
Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions